Yuanshen Huang - Concepedia

Author

Yuanshen Huang

Also Known As

Huang, Yuanshen, Karen Holfeld, Sandra Holdsworth, Y. F. Huang, Y. Huang, Yuan-Shen Huang, Yuan-shen Huang, Yuanshen Huang, Yuanshen Huang (295095)

Publications

735

Citations

H-Index

Concepts

All Affiliations

University of British Columbia BC Cancer Agency Anhui Medical University McGill University Health Centre Brigham and Women's Hospital

About

Yuanshen Huang is an author at University of British Columbia specializing in medicine, autoimmunity, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	286
2	Immunology	2	2	98
3	Pathology	2	2	180
4	Allergy	1	1	23
5	Cell Biology	1	1	75

Yuanshen Huang

Publications

615

Citations

H-Index

Page 1

	Year	Citations
Transcriptome Analysis Reveals Markers of Aberrantly Activated Innate Immunity in Vitiligo Lesional and Non-Lesional Skin Richard Yu, Raewyn Broady, Yuanshen Huang, PLoS ONE	2012	119
Molecular Markers of Early-Stage Mycosis Fungoides Yaohua Zhang, Yang Wang, Richard Yu, Journal of Investigative Dermatology Diagnostic MycologyMolecular MarkersPathogenesisPathologyMedicine	2012	105
The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH) Rayeheh Bahar, Pingyu Zhou, Yudan Liu, Journal of the American Academy of Dermatology Psychological Co-morbiditiesPsychiatryComorbid Psychiatric DisorderDepressionPsychiatric Disorder	2016	83
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines Ivan V. Litvinov, Brendan Cordeiro, Simon Fredholm, Cell Cycle T-regulatory CellImmunologyPathologyDermatologyImmunotherapy	2014	75
Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma Yuanshen Huang, Mingwan Su, Xiaoyan Jiang, Blood	2014	67
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis Yuanshen Huang, Ivan V. Litvinov, Yang Wang, Oncotarget	2014	63
Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients Ivan V. Litvinov, Brendan Cordeiro, Yuanshen Huang, Clinical Cancer Research	2014	46
Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials Ruiqin Mai, Songxia Zhou, Weixiang Zhong, Oncotarget	2015	24
IL-10 is overexpressed in human cutaneous T-cell lymphoma and is required for maximal tumor growth in a mouse model Xuesong Wu, Daniel K. Hsu, Kang-Hsin Wang, Leukemia & lymphoma/Leukemia and lymphoma ImmunologyImmune RegulationImmunologic MechanismDermatologyImmunotherapy	2018	23
Computer-Aided Discovery of Small Molecule Inhibitors of Thymocyte Selection-Associated High Mobility Group Box Protein (TOX) as Potential Therapeutics for Cutaneous T-Cell Lymphomas Vibudh Agrawal, Mingwan Su, Yuanshen Huang, Molecules	2019	10

Page 1